跳至主要内容
临床试验/NCT05050825
NCT05050825Unknown不适用

Validation of an Assisted Medical Care Strategy Composed of a Clinical Decision Support System and RDTs to Reduce Antibiotic Prescription in Non-severe Acute Disease in Children 15 Years Old and Younger in Senegal

Foundation for Innovative New Diagnostics, Switzerland4 个研究点 分布在 1 个国家目标入组 470 人开始时间: 2021年5月3日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
470
试验地点
4
主要终点
Non-inferiority of the CDSA strategy when compared to routine practice in terms of clinical status assessed at Day 7

研究概览

简要总结

This trial aims to validate a novel clinical care strategy based on a electronic clinical decision support algorithm (CDSA) combined with point of care rapid diagnostic tests by evaluating its impact on antibiotic prescription and clinical outcome of children and adolescent presenting at primary healthcare facilities with non-severe acute illness compared to routine practice. The trial also aims to assess the usability of the CDSA strategy. The study will be conducted in primary healthcare facilities across different epidemiological regions of Senegal.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
6 Months 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Ongoing fever or diarrhea
  • ongoing fever will be defined objectively or as a reported fever, defined as : axillary temperature ≥37.5°C or tympanic, oral or rectal temperature ≥38.0°C; and fever duration ≤ 10 days
  • ongoing diarrhea will be defined as at least 3 abnormal stools during the last 24hrs
  • First consultation for the current illness
  • Feasibility of contact between the patient (or his/her designated relative) and the study team at day 3 and day 7
  • Written informed consent by the caretaker/legally acceptable representative

排除标准

  • Infants less than 6 months of age
  • Age ≥ 15 years
  • Clinical status requiring immediate transfer to an appropriate care facility/ severe illness

结局指标

主要结局

Non-inferiority of the CDSA strategy when compared to routine practice in terms of clinical status assessed at Day 7

时间窗: 4 months

This will be measured as point estimates of the percent change of patient with resolved illness at Day 7 in the intervention arm, as compared to the control arm.

Superiority of the CDSA strategy when compared to routine practice in terms of antibiotic prescription at Day 0

时间窗: 4 months

This will be measured as point estimates of the percent change of antibiotic prescription at Day 0 in the intervention arm, as compared to the control arm and to site-specific historical data. This measure aims to assess rational use of antibiotics using the CDSA strategy compared to routine practice.

次要结局

  • Diagnostic performance of the dengue rapid diagnostic test (RDT)(4 months)
  • Antibiotic prescription rate during 7 days of follow-up in the intervention arm compared to the control arm(4 months)
  • Identification of risk factors associated with viral and bacterial infections(4 months)

研究者

发起方
Foundation for Innovative New Diagnostics, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验